FDA.reportPublic FDA data

FYARRO 100 MG Injection

RxCUI
2586868
RxNorm name
FYARRO 100 MG Injection
Display name
FYARRO 100 MG Injection
Full name
FYARRO 100 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FYARROSIROLIMUSAadi Bioscience, Inc.0f9bb784-53e2-46f9-a65d-1c6c2a230eaf2026-05-19Warnings, Adverse reactionsExact identifier
rxcui: 2586868

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0f9bb784-53e2-46f9-a65d-1c6c2a230eafFYARRO 100 MG Injection [PSN] · sirolimus 100 MG Injection [Fyarro] [SBD] · Fyarro 100 MG Injection [SY]39These highlights do not include all the information needed to use FYARRO safely and effectively. See full prescribing information for FYARRO. FYARRO ® (sirolimus protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 202120260519